Skip to main content
logo
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.940
+0.020 (1.04%)
At close: Jul 24, 2026, 4:00 PM EDT
1.950
+0.010 (0.51%)
After-hours: Jul 24, 2026, 5:31 PM EDT

Alaunos Therapeutics Revenue

Alaunos Therapeutics had revenue of $3.00K in the twelve months ending March 31, 2026, down -70.00% year-over-year. In the year 2025, Alaunos Therapeutics had annual revenue of $5.00K, down -50.00%.

Revenue (ttm)
$3.00K
Revenue Growth
-70.00%
P/S Ratio
1,566.32
Revenue / Employee
$3,000
Employees
1
Market Cap
4.70M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.00K-5.00K-50.00%
Dec 31, 202410.00K5.00K100.00%
Dec 31, 20235.00K-2.92M-99.83%
Dec 31, 20222.92M2.52M634.17%
Dec 31, 2021398.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018146.00K-6.24M-97.71%
Dec 31, 20176.39M-472.00K-6.88%
Dec 31, 20166.86M2.53M58.38%
Dec 31, 20154.33M2.96M215.51%
Dec 31, 20141.37M573.00K71.63%
Dec 31, 2013800.00K--
Dec 31, 2012800.00K133.00K19.94%
Dec 31, 2011667.00K--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ensysce Biosciences4.71M
Bio Green Med Solution1.53M
PMGC Holdings1.27M
Silo Pharma72.10K
Cardio Diagnostics Holdings16.57K
Ernexa Therapeutics1,000.00
Revenue Rankings

TCRT News

More News